INHIBITION OF MOUSE MAMMARY-CARCINOMA DEVELOPMENT WITH DOXORUBICIN INLIPOSOMES

Authors
VAAGE J WORKING P USTER P
Citation
J. Vaage et al., INHIBITION OF MOUSE MAMMARY-CARCINOMA DEVELOPMENT WITH DOXORUBICIN INLIPOSOMES, International journal of cancer, 75(1), 1998, pp. 158-159
Citations number
9
Categorie Soggetti
Oncology
Journal title
International journal of cancer → ACNP
ISSN journal
00207136
Volume
75
Issue
1
Year of publication
1998
Pages
158 - 159
Database
ISI
SICI code
0020-7136(1998)75:1<158:IOMMDW>2.0.ZU;2-Y
Abstract
Monthly treatments with intravenous doxorubicin encapsulated in long c irculating, sterically stabilized liposomes delayed the appearance of primary mammary carcinomas and reduced the final incidence from 49 in 50 untreated mice to 46 in 87 treated mice. No toxic side effects of t he treatments were observed. (C) 1998 Wiley-Liss, Inc.